Literature DB >> 12393449

Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells.

Yutaka Kawano1, Masayoshi Kobune, Miki Yamaguchi, Kiminori Nakamura, Yoshinori Ito, Katsunori Sasaki, Sho Takahashi, Takafumi Nakamura, Hiroki Chiba, Tsutomu Sato, Takuya Matsunaga, Hiroshi Azuma, Kenji Ikebuchi, Hisami Ikeda, Junji Kato, Yoshiro Niitsu, Hirofumi Hamada.   

Abstract

We developed a new human stromal cell line that could expand human hematopoietic progenitor/stem cells. Primary human bone marrow stromal cells were infected with retrovirus containing the human telomerase catalytic subunit (hTERT) gene, resulting in increased population doubling and the acquisition of cell immortalization. Characteristics of the hTERT-transduced stromal (hTERT-stromal) cells were identical with those of the primary stromal cells in terms of morphologic appearance and expression of surface antigens. Human cord blood (CB) CD34(+) cells were expanded by coculture with primary stromal or hTERT-stromal cells in the presence of stem cell factor, thrombopoietin, and Flk-2/Flt-3 ligand under serum-free condition. The degree of expansion of CD34(+) cells and total number of colony-forming units in culture (CFU-Cs) after 2 weeks' coculture with the hTERT-stromal cells were nearly the same as those after 2 weeks' coculture with primary stromal cells (CD34(+) cells, 118-fold +/- 8-fold versus 117-fold +/- 13-fold; CFU-Cs, 71-fold +/- 5-fold versus 67-fold +/- 5-fold of initial cell number). CB expansion on hTERT-stromal cells occurred at a similar rate through 7 weeks. In contrast, the rate of CB expansion on primary stromal cells had drastically declined at 7 weeks. In nonobese diabetic/severe combined immunodeficiency (SCID) mice, the degree of engraftment of SCID-repopulating cells that had been cocultured with hTERT-stromal cells for 4 weeks was significantly higher than that of precocultured CB cells. These results indicate that this hTERT-stromal cell line could be useful for ex vivo expansion of hematopoietic progenitor/stem cells and for analyzing the microenvironment of human bone marrow.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393449     DOI: 10.1182/blood-2002-04-1268

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor.

Authors:  Taghi Manshouri; Zeev Estrov; Alfonso Quintás-Cardama; Jan Burger; Ying Zhang; Ana Livun; Liza Knez; David Harris; Chad J Creighton; Hagop M Kantarjian; Srdan Verstovsek
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

2.  Do hematopoietic cells exposed to a neurogenic environment mimic properties of endogenous neural precursors?

Authors:  P Walczak; N Chen; J E Hudson; A E Willing; S N Garbuzova-Davis; S Song; P R Sanberg; J Sanchez-Ramos; P C Bickford; T Zigova
Journal:  J Neurosci Res       Date:  2004-04-15       Impact factor: 4.164

Review 3.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

4.  Establishment of a stroma-dependent human acute myelomonocytic leukemia cell line, NAMO-2, with FLT3 tandem duplication.

Authors:  Akihiro Abe; Hitoshi Kiyoi; Manabu Ninomiya; Tomio Yamazaki; Takuhei Murase; Kazutaka Ozeki; Momoko Suzuki; Fumihiko Hayakawa; Akira Katsumi; Nobuhiko Emi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

5.  Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition.

Authors:  Masayoshi Kobune; Yutaka Kawano; Junji Kato; Yoshinori Ito; Hiroki Chiba; Kiminori Nakamura; Akihito Fujimi; Takuya Matsunaga; Hirofumi Hamada; Yoshiro Niitsu
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

6.  Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

Authors:  T Honma; O Honmou; S Iihoshi; K Harada; K Houkin; H Hamada; J D Kocsis
Journal:  Exp Neurol       Date:  2005-06-20       Impact factor: 5.330

7.  Generation and characterization of an immortalized human mesenchymal stromal cell line.

Authors:  Magne Skårn; Paul Noordhuis; Meng-Yu Wang; Marjan Veuger; Stine Henrichson Kresse; Eivind Valen Egeland; Francesca Micci; Heidi Maria Namløs; Anne-Mari Håkelien; Solveig Mjelstad Olafsrud; Susanne Lorenz; Guttorm Haraldsen; Gunnar Kvalheim; Leonardo Andrés Meza-Zepeda; Ola Myklebost
Journal:  Stem Cells Dev       Date:  2014-06-30       Impact factor: 3.272

8.  Differential effects of HOXB4 and NUP98-HOXA10hd on hematopoietic repopulating cells in a nonhuman primate model.

Authors:  Korashon L Watts; Xiaobing Zhang; Brian C Beard; Sum Ying Chiu; Grant D Trobridge; R Keith Humphries; Hans-Peter Kiem
Journal:  Hum Gene Ther       Date:  2011-09-06       Impact factor: 5.695

Review 9.  Optimizing autologous cell grafts to improve stem cell gene therapy.

Authors:  Nikoletta Psatha; Garyfalia Karponi; Evangelia Yannaki
Journal:  Exp Hematol       Date:  2016-04-19       Impact factor: 3.084

10.  Interferon-gamma increased epithelial barrier function via upregulating claudin-7 expression in human submandibular gland duct epithelium.

Authors:  Ayumi Abe; Kenichi Takano; Takashi Kojima; Kazuaki Nomura; Takuya Kakuki; Yakuto Kaneko; Motohisa Yamamoto; Hiroki Takahashi; Tetsuo Himi
Journal:  J Mol Histol       Date:  2016-03-08       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.